LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...

Enzymes are molecular machines that carry out the chemical reactions that sustain all life, an ability that has captured the attention of scientists ...

During a Case-Based Roundtable® event, Nitin Jain, MD, and participants discussed treating a patient with CLL after ...

The global Microcarriers market, valued at US$2.03 billion in 2023, is forecasted to grow at a robust CAGR of 8.0%, reaching US$2.08 billion in 2024 and an impressive US$3.05 billion by 2029. Market ...

On August 15, Tevogen Bio entered into a definitive agreement for a $6 million Series C Preferred Stock investment (“Series C”). The shares of the Series C have a 7.5% annual dividend and are ...

Tevogen Bio remains steadfast in its mission to pioneer accessible and affordable precision medicine while advocating for fair and transparent market participation.

ClearDATA®, healthcare's trusted partner for managed cloud security, compliance and operational resiliency solutions, has unveiled its 2024 Healthcare Threat Report, offering a comprehensive analysis ...

Radiesse and Restylane Lyft are the only two fillers that are FDA-approved for use in the hands, says Dr. Fabi, adding that ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.

Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...

Aging is a privilege, but it also brings risks—including an increased likelihood of developing age-related diseases including ...